Regulatory Affairs Consulting
Expert Guidance for Product Approval
At Medwisdom Lifescience, we provide regulatory affairs consultation combined with strategic planning to simplify your path to product approval. Our team—including former FDA managers, NDA application reviewers, and seasoned industry experts—is dedicated to delivering simple, reliable, and effective regulatory solutions that overcome compliance hurdles and challenges.
We specialize in providing transparent and efficient regulatory consultation to help you mitigate potential delays and meet your goals on time. Our services cover preparation of CTD, ACTD, and eCTD dossiers for product registration in compliance with global standards.
We support brand pharmaceutical products as well as generic drugs, preparing and submitting key FDA-required documents such as:
- Investigational New Drug Application (IND) for clinical trial approval
- New Drug Application (NDA) for innovative drugs
- Abbreviated New Drug Application (ANDA) for generics
- Drug Master File (DMF) preparation (Type I, II, III, IV)
- And many more regulatory submissions